These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21187448)

  • 21. Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis.
    Biswas PS; Banerjee K; Kim B; Rouse BT
    J Immunol; 2004 Mar; 172(6):3736-44. PubMed ID: 15004178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis.
    Sarangi PP; Kim B; Rouse BT
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5425-33. PubMed ID: 18689698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEDF Reduces the Severity of Herpetic Simplex Keratitis in Mice.
    Tian X; Wang T; Zhang S; Wang Q; Hu X; Ge C; Xie L; Zhou Q
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2923-2931. PubMed ID: 30025136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology.
    Jiang Y; Yin X; Stuart PM; Leib DA
    mBio; 2015 Oct; 6(6):e01426-15. PubMed ID: 26507231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.
    Rowe AM; Yun H; Treat BR; Kinchington PR; Hendricks RL
    J Immunol; 2017 Feb; 198(4):1706-1717. PubMed ID: 28062697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses.
    Kim B; Sarangi PP; Azkur AK; Kaistha SD; Rouse BT
    Microbes Infect; 2008 Mar; 10(3):302-12. PubMed ID: 18325811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary herpes simplex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids.
    Stumpf TH; Case R; Shimeld C; Easty DL; Hill TJ
    J Gen Virol; 2002 Jul; 83(Pt 7):1579-1590. PubMed ID: 12075076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.
    Kim B; Sarangi PP; Lee Y; Deshpande Kaistha S; Lee S; Rouse BT
    J Leukoc Biol; 2006 Dec; 80(6):1405-15. PubMed ID: 16997857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of CXCL10 aggravates herpes stromal keratitis with reduced primary neutrophil influx in mice.
    Shen FH; Wang SW; Yeh TM; Tung YY; Hsu SM; Chen SH
    J Virol; 2013 Aug; 87(15):8502-10. PubMed ID: 23720717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the role of retinoic acid in virus induced inflammatory response in cornea.
    Jaggi U; Varanasi SK; Bhela S; Rouse BT
    Microbes Infect; 2018; 20(6):337-345. PubMed ID: 29842984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolvin E1 Regulates Th17 Function and T Cell Activation.
    Oner F; Alvarez C; Yaghmoor W; Stephens D; Hasturk H; Firatli E; Kantarci A
    Front Immunol; 2021; 12():637983. PubMed ID: 33815391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling.
    Veiga-Parga T; Suryawanshi A; Rouse BT
    PLoS Pathog; 2011 Dec; 7(12):e1002427. PubMed ID: 22174686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.
    Jin Y; Arita M; Zhang Q; Saban DR; Chauhan SK; Chiang N; Serhan CN; Dana R
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4743-52. PubMed ID: 19407006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supplementing the Diet with Sodium Propionate Suppresses the Severity of Viral Immuno-inflammatory Lesions.
    Sumbria D; Berber E; Rouse BT
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlling herpetic stromal keratitis by modulating lymphotoxin-alpha-mediated inflammatory pathways.
    Veiga-Parga T; Giménez F; Mulik S; Chiang EY; Grogan JL; Rouse BT
    Microbes Infect; 2013; 15(10-11):677-87. PubMed ID: 23850656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of miR-155 in the pathogenesis of herpetic stromal keratitis.
    Bhela S; Mulik S; Gimenez F; Reddy PB; Richardson RL; Varanasi SK; Jaggi U; Xu J; Lu PY; Rouse BT
    Am J Pathol; 2015 Apr; 185(4):1073-84. PubMed ID: 25700796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators.
    Sehrawat S; Suryawanshi A; Hirashima M; Rouse BT
    J Immunol; 2009 Mar; 182(5):3191-201. PubMed ID: 19234217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical antisense-oligonucleotides targeting IFN-gamma mRNA improve incidence and severity of herpetic stromal keratitis by cytokine specific and sequence unspecific effects.
    Wasmuth S; Bauer D; Steuhl KP; Heiligenhaus A
    Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):443-51. PubMed ID: 18030487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice.
    Kim TH; Kim GD; Jin YH; Park YS; Park CS
    Int Immunopharmacol; 2012 Dec; 14(4):384-91. PubMed ID: 22951188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury.
    Seki H; Fukunaga K; Arita M; Arai H; Nakanishi H; Taguchi R; Miyasho T; Takamiya R; Asano K; Ishizaka A; Takeda J; Levy BD
    J Immunol; 2010 Jan; 184(2):836-43. PubMed ID: 20007539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.